Newsbenzinga
Shattuck Labs Plans To Evaluate SL-325 In Phase 2 Clinical Trial In Patients With Moderate To Severe Hidradenitis Suppurativa
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…